BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2126027)

  • 1. [The study on the immunological effect of sizofilan combined with radiotherapy in patients with uterine cervical cancer].
    Sekiguchi I; Suzuki M; Izumi A; Aida I; Tamada T
    Nihon Gan Chiryo Gakkai Shi; 1990 Nov; 25(11):2659-64. PubMed ID: 2126027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Electron microscopic and immunological studies concerning the effect on the antitumor activity of sizofiran (SPG) combined with radiotherapy for cervical cancer].
    Hasegawa K; Nishimura R; Kinugasa M; Okamura M; Kimura A; Ohtsu F; Takeuchi K; Mizuhira V
    Nihon Gan Chiryo Gakkai Shi; 1990 Oct; 25(10):2549-61. PubMed ID: 2124607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The cytoimmunological effect of concomitant use of sizofiran (SPG) on advanced uterine cervical cancer treated with radiation].
    Iwanari O; Miyako J; Ryuko K; Date Y; Moriyama M; Moriyama M; Kijima S; Yoshino N; Kitao M
    Nihon Gan Chiryo Gakkai Shi; 1989 Oct; 24(10):2355-61. PubMed ID: 2533231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical effect of sizofiran combined with irradiation in cervical cancer patients: a randomized controlled study. Cooperative Study Group on SPG for Gynecological Cancer.
    Noda K; Takeuchi S; Yajima A; Akiya K; Kasamatsu T; Tomoda Y; Ozawa M; Sekiba K; Sugimori H; Hashimoto S
    Jpn J Clin Oncol; 1992 Feb; 22(1):17-25. PubMed ID: 1573785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Studies on immunotherapy of uterine cervical cancer by administration of schizophyllan (SPG) (author's transl)].
    Hamazaki Y; Kuramoto M; Okamura K; Yajima A; Higashiiwai H; Suzuki M
    Nihon Sanka Fujinka Gakkai Zasshi; 1980 Jul; 32(7):929-35. PubMed ID: 6453913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activated (HLA-DR+) T-lymphocyte subsets in cervical carcinoma and effects of radiotherapy and immunotherapy with sizofiran on cell-mediated immunity and survival.
    Miyazaki K; Mizutani H; Katabuchi H; Fukuma K; Fujisaki S; Okamura H
    Gynecol Oncol; 1995 Mar; 56(3):412-20. PubMed ID: 7705677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological modulation of lymphocyte subpopulation in cervical cancer tissue by sizofiran and OK-432.
    Gorai I; Yanagibashi T; Minaguchi H
    Gynecol Oncol; 1992 Feb; 44(2):137-46. PubMed ID: 1371977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evaluation of sizofilan as assistant immunotherapy in treatment of head and neck cancer.
    Kimura Y; Tojima H; Fukase S; Takeda K
    Acta Otolaryngol Suppl; 1994; 511():192-5. PubMed ID: 7911266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical evaluation of schizophyllan combined with irradiation in patients with cervical cancer. A randomized controlled study.
    Okamura K; Suzuki M; Chihara T; Fujiwara A; Fukuda T; Goto S; Ichinohe K; Jimi S; Kasamatsu T; Kawai N
    Cancer; 1986 Aug; 58(4):865-72. PubMed ID: 2941141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of 5'-DFUR used concurrently in radiotherapy and immunotherapy uterine cervical cancer--pilot study. Study of 5'-DFUR for Uterine Cervical Cancer].
    Hatae M; Noda K; Yajima A; Sato S; Terashima Y; Ochiai K; Sasaki H; Mizutani K; Honjo H; Yamamoto T; Ozaki M; Yamamoto K; Hasegawa K; Nishimura R; Kudo T; Kobashi Y; Yakushiji M; Sugiyama T; Hasuo Y; Onishi Y
    Gan To Kagaku Ryoho; 1998 Apr; 25(5):705-11. PubMed ID: 9571968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Improvement in the effects of radiation therapy with BRM].
    Inomata T; Ogawa Y; Nishioka A; Maeda T; Seguchi H
    Gan No Rinsho; 1990 Oct; 36(13):2278-85. PubMed ID: 2123503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intratumoral administration of sizofiran activates Langerhans cell and T-cell infiltration in cervical cancer.
    Nakano T; Oka K; Hanba K; Morita S
    Clin Immunol Immunopathol; 1996 Apr; 79(1):79-86. PubMed ID: 8612354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of bitter melon (Momordica charantia Linn) on level and function of natural killer cells in cervical cancer patients with radiotherapy.
    Pongnikorn S; Fongmoon D; Kasinrerk W; Limtrakul PN
    J Med Assoc Thai; 2003 Jan; 86(1):61-8. PubMed ID: 12678140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical evaluation of sizofiran combined with irradiation in patients with cervical cancer. A randomized controlled study; a five-year survival rate.
    Okamura K; Suzuki M; Chihara T; Fujiwara A; Fukuda T; Goto S; Ichinohe K; Jimi S; Kasamatsu T; Kawai N
    Biotherapy; 1989; 1(2):103-7. PubMed ID: 2534912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of thymidine phosphorylase immunostaining in patients with uterine cervical cancer treated concurrently with doxifluridine, radiotherapy and immunotherapy.
    Sato S; Yajima A; Sasaki H; Mizutani K; Honjo H; Yamamoto K; Ozaki M; Hasegawa K; Kudo T; Yakushiji M; Hatae M; Noda K
    Oncol Rep; 2001; 8(2):239-44. PubMed ID: 11182033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of concomitant use of doxifluridine, radiotherapy and immunotherapy in patients with advanced cervical cancer.
    Yamamoto K; Noda K; Hatae M; Kudo T; Hasegawa K; Nishimura R; Honjo H; Yajima A; Sato S; Mizutani K; Yakushiji M; Terashima Y; Ochiai K; Sasaki H; Ozaki M
    Oncol Rep; 2001; 8(2):273-7. PubMed ID: 11182039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination therapy of pions and SPG (Sonifilan, Schizophyllan), a biological response modifier for mouse tumor systems.
    Ogawa Y; Goodman GB; Chaplin DJ; Grulkey W; Lam GK
    Int J Radiat Oncol Biol Phys; 1990 Jun; 18(6):1415-20. PubMed ID: 2142485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor activity of Langerhans cells in radiation therapy for cervical cancer and its modulation with SPG administration.
    Nakano T; Oka K; Sugita T; Tsunemoto H
    In Vivo; 1993; 7(3):257-63. PubMed ID: 8357967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NK cell activity in the presence of IL-12 is a prognostic assay to neoadjuvant chemotherapy in cervical cancer.
    Cosiski Marana HR; Santana da Silva J; Moreira de Andrade J
    Gynecol Oncol; 2000 Sep; 78(3 Pt 1):318-23. PubMed ID: 10985887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Augmentative effect of sizofiran on the immune functions of regional lymph nodes in patients with cervical cancer].
    Shimizu Y; Teshima H; Chen JT; Fujimoto I; Hasumi K; Masubuchi K
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 Jun; 43(6):581-8. PubMed ID: 1906916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.